Medgenics Medical Overview
Medgenics Inc is focused on using genomic medicine to improve the lives of children and adults with rare and difficult-to-treat diseases. The company's flagship product is TARGT (Transduced Autologous Restorative Gene Therapy). The technology allows patients to produce, within their bodies and on a long-term basis, their own natural human protein therapy for the treatment of a range of chronic diseases. The process involves removal, treatment, and re-implantation of micro-organs.
Latest News
No news articles.
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | — |
| Rounds | — |
| Investors | — |
Team Members
0
Web & Social Links
| Website | www.medgenics.com |
Photos & Videos
No files yet
Medgenics Medical Business
Sector
—Target Customer
—Core Technology
—Medgenics Medical Financials
Medgenics Medical Lifecycle
Medgenics Medical News
0 articlesNo news articles.
Medgenics Medical Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Medgenics Medical Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 87/100 |
| Missing | not claimed |
| Last update | 2017-11-20T00:00:00.000Z |
| Hidden | Pending approval (visible: 0) |
| Status detail | Public on NYSE on Apr, 2011; |